These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 26423017)

  • 1. Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Shin ES; Ann SH; Balbir Singh G; Lim KH; Kleber FX; Koo BK
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):193-200. PubMed ID: 26423017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Chung JH; Shin ES; Her AY; Lee JM; Doh JH; Nam CW; Koo BK
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):179-185. PubMed ID: 31598811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty.
    Her AY; Shin ES; Lee JM; Garg S; Doh JH; Nam CW; Koo BK
    Int J Cardiovasc Imaging; 2018 Sep; 34(9):1339-1347. PubMed ID: 29696453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized trial of paclitaxel-coated balloon versus bare-metal stent in high bleeding risk patients with de novo coronary artery lesions.
    Shin ES; Lee JM; Her AY; Chung JH; Eun Lee K; Garg S; Nam CW; Doh JH; Koo BK
    Coron Artery Dis; 2019 Sep; 30(6):425-431. PubMed ID: 31009399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.
    Vos NS; van der Schaaf RJ; Amoroso G; Herrman JP; Patterson MS; Slagboom T; Vink MA
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1213-21. PubMed ID: 26370515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.
    Nijhoff F; Stella PR; Troost MS; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Agostoni P
    Clin Res Cardiol; 2016 May; 105(5):401-11. PubMed ID: 26541146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fractional flow reserve and angiographic characteristics after balloon angioplasty in de novo coronary lesions.
    Chung JH; Lee KE; Her AY; Lee JM; Doh JH; Nam CW; Koo BK; Shin ES
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1945-1954. PubMed ID: 31214851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R;
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.
    Loh JP; Stella PR; Sangiorgi G; Silber S; Stahnke S; von Strandmann RP; Torguson R; Waksman R
    Cardiovasc Revasc Med; 2014 Jan; 15(1):23-8. PubMed ID: 24444473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.
    Hee L; Terluk A; Thomas L; Hopkins A; Juergens CP; Lo S; French JK; Mussap CJ
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):375-382. PubMed ID: 27113534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels.
    Giannini F; Latib A; Ancona MB; Costopoulos C; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):380-386. PubMed ID: 28109036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.
    Kufner S; Cassese S; Valeskini M; Neumann FJ; Schulz-Schüpke S; Hoppmann P; Fusaro M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2015 Jun; 8(7):877-84. PubMed ID: 26003022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions.
    Her AY; Ann SH; Singh GB; Kim YH; Yoo SY; Garg S; Koo BK; Shin ES
    Yonsei Med J; 2016 Mar; 57(2):337-41. PubMed ID: 26847284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
    Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.